Morgan Stanley analyst Meta Marshall maintains Five9 (NASDAQ:FIVN) with a Equal-Weight and lowers the price target from $75 to $55.
Critical Insights From Moderna Analyst Ratings: What You Need To Know
Across the recent three months, 7 analysts have shared their insights on Moderna (NASDAQ:MRNA), expressing a variety of…